Outcomes of gracilis muscle interposition for rectourethral fistulas caused by treatment of prostate cancer
© 2023. Springer Nature Switzerland AG..
BACKGROUND: Gracilis muscle interposition (GMI) has been associated with favorable outcomes in treating complex perianal fistulas. Outcomes of GMI may vary according to the fistula etiology, particularly between rectovaginal fistulas in women and rectourethral fistulas (RUF) in men. The aim of this study was to assess the outcome of GMI to treat RUF acquired after prostate cancer treatment.
METHODS: This retrospective cohort study included male patients treated with GMI for RUF acquired after prostate cancer treatment between January 2000 and December 2018 in the Department of Colorectal Surgery, Cleveland Clinic Florida. The primary outcome was the success of GMI, defined as complete healing of RUF without recurrence. Secondary outcomes were length of hospital stay and postoperative complications.
RESULTS: This study included 53 male patients with a median age of 68 (range, 46-85) years. Patients developed RUF after treatment of prostate cancer with radiation (52.8%), surgery (34%), or transurethral resection of the prostate (TURP) (13.2%). Median hospital stay was 5 (IQR, 4-7) days. Twenty (37.7%) patients experienced 25 complications, the most common being wound infection and dehiscence. Primary healing after GMI was achieved in 28 (52.8%) patients. Fifteen additional patients experienced successful healing of RUF after additional procedures, for a total success rate of 81.1%. Median time to complete healing was 8 (range, 4-56) weeks. The only significant factor associated with outcome of GMI was wound dehiscence (p = 0.008).
CONCLUSIONS: Although the initial success rate of GMI was approximately 53%, it increased to 81% after additional procedures. Complications after GMI were mostly minor, with wound complications being the most common. Perianal wound dehiscence was significantly associated with failure of healing of RUF after GMI.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Techniques in coloproctology - 27(2023), 10 vom: 21. Okt., Seite 937-944 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Emile, S H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Gracilis muscle interposition |
|---|
| Anmerkungen: |
Date Completed 11.09.2023 Date Revised 21.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10151-023-02759-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM353065382 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM353065382 | ||
| 003 | DE-627 | ||
| 005 | 20231227135155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10151-023-02759-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1234.xml |
| 035 | |a (DE-627)NLM353065382 | ||
| 035 | |a (NLM)36800073 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Emile, S H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of gracilis muscle interposition for rectourethral fistulas caused by treatment of prostate cancer |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.09.2023 | ||
| 500 | |a Date Revised 21.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Springer Nature Switzerland AG. | ||
| 520 | |a BACKGROUND: Gracilis muscle interposition (GMI) has been associated with favorable outcomes in treating complex perianal fistulas. Outcomes of GMI may vary according to the fistula etiology, particularly between rectovaginal fistulas in women and rectourethral fistulas (RUF) in men. The aim of this study was to assess the outcome of GMI to treat RUF acquired after prostate cancer treatment | ||
| 520 | |a METHODS: This retrospective cohort study included male patients treated with GMI for RUF acquired after prostate cancer treatment between January 2000 and December 2018 in the Department of Colorectal Surgery, Cleveland Clinic Florida. The primary outcome was the success of GMI, defined as complete healing of RUF without recurrence. Secondary outcomes were length of hospital stay and postoperative complications | ||
| 520 | |a RESULTS: This study included 53 male patients with a median age of 68 (range, 46-85) years. Patients developed RUF after treatment of prostate cancer with radiation (52.8%), surgery (34%), or transurethral resection of the prostate (TURP) (13.2%). Median hospital stay was 5 (IQR, 4-7) days. Twenty (37.7%) patients experienced 25 complications, the most common being wound infection and dehiscence. Primary healing after GMI was achieved in 28 (52.8%) patients. Fifteen additional patients experienced successful healing of RUF after additional procedures, for a total success rate of 81.1%. Median time to complete healing was 8 (range, 4-56) weeks. The only significant factor associated with outcome of GMI was wound dehiscence (p = 0.008) | ||
| 520 | |a CONCLUSIONS: Although the initial success rate of GMI was approximately 53%, it increased to 81% after additional procedures. Complications after GMI were mostly minor, with wound complications being the most common. Perianal wound dehiscence was significantly associated with failure of healing of RUF after GMI | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Gracilis muscle interposition | |
| 650 | 4 | |a Outcome | |
| 650 | 4 | |a Prostate cancer | |
| 650 | 4 | |a Rectourethral fistulas | |
| 700 | 1 | |a Horesh, N |e verfasserin |4 aut | |
| 700 | 1 | |a Strassmann, V |e verfasserin |4 aut | |
| 700 | 1 | |a Garoufalia, Z |e verfasserin |4 aut | |
| 700 | 1 | |a Gefen, R |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, P |e verfasserin |4 aut | |
| 700 | 1 | |a Ray-Offor, E |e verfasserin |4 aut | |
| 700 | 1 | |a Dasilva, G |e verfasserin |4 aut | |
| 700 | 1 | |a Wexner, S D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Techniques in coloproctology |d 1998 |g 27(2023), 10 vom: 21. Okt., Seite 937-944 |w (DE-627)NLM09553945X |x 1128-045X |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2023 |g number:10 |g day:21 |g month:10 |g pages:937-944 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10151-023-02759-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2023 |e 10 |b 21 |c 10 |h 937-944 | ||